Helping providers resolve denials five times faster and cut denial rates by 70%

帮助供应商解决问题的速度快五倍，并将拒绝率降低70%

NEW YORK

纽约

,

，

April 22, 2026

2026年4月22日

/PRNewswire/ -- Amperos Health, the first insurance revenue recovery partner capable of working denials end-to-end entirely with AI, announced today that it has closed a $16 million Series A funding round, led by Bessemer Venture Partners, with participation from Uncork Capital and Neo.

/PRNewswire/ -- Amperos Health 是首家能够完全通过人工智能端到端处理拒绝索赔的保险收入追回合作伙伴，今天宣布已完成 1600 万美元的 A 轮融资，由 Bessemer Venture Partners 领投，Uncork Capital 和 Neo 参与投资。

The raise comes as Amperos launches the industry's first AI-native denial management and revenue recovery solution for healthcare providers. Amperos' agentic capabilities provide end-to-end denial and collection automation, while a team of subject matter experts provides judgment and expertise for complex and difficult-to-recover claims.

此次融资正值Amperos推出医疗行业首个原生人工智能的拒绝管理与收入追回解决方案之际。Amperos的代理能力提供端到端的拒绝和收款自动化，同时一支主题专家团队为复杂且难以追回的索赔提供判断和专业知识支持。

Amperos then delivers detailed insights into how providers can optimize their billing and collections processes to prevent future denials. To date, Amperos has served over 3,000 clinical locations across all 50 states, driving nearly $700 million of revenue recovered per year across over 500,000 claims. .

安培罗斯随后提供了关于供应商如何优化其账单和收款流程以防止未来拒绝的详细见解。迄今为止，安培罗斯已经服务于全美50个州的3000多个临床地点，每年推动回收近7亿美元的收入，涉及超过50万项索赔。

'Complexity in healthcare revenue cycle management (RCM) should not be the norm, and that's why our mission at Amperos is to streamline the denial and collections process so providers can focus on what matters most – operating their practices and serving their patients,' said Michal Miernowski, CEO and Co-Founder of Amperos Health.

“医疗保健收入周期管理（RCM）的复杂性不应成为常态，这就是为什么我们在Amperos的使命是简化拒绝和收款流程，让医疗服务提供者能够专注于最重要的事情——运营他们的诊所并服务患者，”Amperos Health首席执行官兼联合创始人米哈尔·米埃尔诺夫斯基表示。

'I'm thrilled to announce our most recent funding round, which will be critical as Amperos accelerates its growth to serve more providers, expands its analytics capabilities and launches new agentic capabilities in other RCM workflows.'.

“我很高兴地宣布我们最近的一轮融资，这将对Amperos加速增长、服务更多供应商、扩展其分析能力以及在其他RCM工作流程中推出新的代理功能起到至关重要的作用。”

Denials are rising in healthcare today, with

当前医疗保健领域的拒付现象正在增加，

12%

12%

of claims denied in 2024, representing a

2024年被拒绝的索赔数量，占

$262 billion

2620亿美元

loss in revenue to providers. Providers then spend more than

供应商的收入损失。然后供应商花费更多

$26 billion

260亿美元

annually in recovering these denied claims, of which

每年在挽回这些被拒绝的索赔中，其中

70%

70%

end up getting paid. And yet,

最终得到报酬。然而，

63

六十三

%

%

of RCM teams are understaffed, while healthcare administration teams face a

RCM团队人员不足，而医疗管理团队面临同样的问题。

32%

32%

annual turnover rate.

年营业额。

These statistics exemplify why Amperos has built a new product that can fill gaps in the RCM workforce while recovering more value in denied revenue. The product manages the full denial management process, from following up through insurance portals and calls, to submitting corrected claims, medical records, and appeals..

这些统计数据说明了为什么 Amperos 构建了一个新产品，该产品可以在 RCM 劳动力方面填补空缺，同时在被拒绝的收入中挽回更多价值。该产品管理整个拒付管理流程，从通过保险门户和电话跟进，到提交更正后的索赔、病历和上诉。

'Denials are one of healthcare's fastest-growing pain points: a growing portion of claims denied, hundreds of billions in lost revenue, and RCM teams that are chronically understaffed. It's a broken process ripe for AI transformation,' said Sofia Guerra, Partner at Bessemer Venture Partners. 'What sets Amperos apart is that they're the first truly agentic AI platform we've seen to automate this workflow end-to-end, from portal follow-ups and calls to corrected claims and appeals, with no handoffs and no gaps.

“拒赔是医疗保健领域增长最快的痛点之一：被拒绝的索赔比例不断增加，数千亿美元的收入损失，以及长期人手不足的收入周期管理团队。这是一个亟需人工智能变革的破碎流程，”贝塞默风险投资公司合伙人索菲亚·格雷拉表示。“Amperos 的突出之处在于，他们是首家真正实现端到端自动化的代理型人工智能平台，从门户网站跟进、电话沟通，到修正索赔和上诉，全程无缝衔接，没有任何断点。”

We're excited to see Amperos continue to grow its impact for customers. The results speak for themselves: 22% more recovered per claim at up to 50% lower cost, creating real financial relief for providers who are already operating on razor-thin margins.'.

我们很高兴看到Amperos继续为客户扩大其影响力。结果不言自明：每次索赔追回的金额增加了22%，而成本却降低了多达50%，为那些已经以微薄利润运营的服务提供商带来了真正的财务缓解。

While other solutions on the market typically automate only part of the denial management process – like calling, writing appeal letters, or navigating payer portals – Amperos is the first and only product in the market to automate end-to-end workflows for denial teams. Amperos uses state-of-the-art LLMs across voice, computer use, and more to complete entire collections workflows and maximize reimbursement at the lowest cost to collect..

虽然市场上的其他解决方案通常只能自动化拒绝管理流程的一部分——例如拨打电话、撰写申诉信或浏览支付方门户——Amperos是市场上首个也是唯一一个能够为拒付团队自动化端到端工作流程的产品。Amperos在语音、计算机使用等方面采用最先进的大型语言模型，完成整个催收工作流程，并以最低的催收费用实现收入最大化。

'Our partnership with Amperos has helped ease the workload that comes with recovering unpaid claims and insurance collections tremendously,' said Valerie DeCaro, Vice President of Revenue Cycle Management at DOCS Dermatology. 'By helping my team work through time-consuming tasks faster and focus on more complex needs, we've been able to recover 24% more claims without increasing headcount.

“我们与Amperos的合作极大地减轻了处理未付索赔和保险收款的工作负担，”DOCS皮肤科的收入周期管理副总裁瓦莱丽·德卡罗表示。“通过帮助我的团队更快地完成耗时的任务，并专注于更复杂的需求，我们在不增加人手的情况下成功多收回了24%的索赔。”

DOCS Dermatology is a provider-first organization, and Amperos Health ensures that our providers are properly compensated for the care they give.'.

DOCS皮肤科是一家以医疗服务提供者为先的组织，Amperos Health确保我们的提供者因他们提供的护理得到适当的补偿。

Amperos Health continues to serve as a partner to providers, building upon the company's

安培罗斯健康公司继续作为供应商的合作伙伴，依托公司的力量不断发展壮大。

$4.2 million seed funding announcement

420万美元种子资金公告

in June 2025. By empowering teams to challenge the notion that healthcare RCM is inherently complex, Amperos is leading a new standard in healthcare where providers can navigate RCM with ease.

2025年6月。通过赋能团队挑战医疗保健RCM固有复杂性的观念，Amperos正在引领医疗保健的新标准，使供应商能够轻松应对RCM。

About Amperos Health:

关于Amperos健康：

Amperos Health is healthcare's first AI-native denial management and revenue recovery solution designed specifically for healthcare providers to combat denials and streamline claims collections for revenue cycle management (RCM) teams. Fully HIPAA-compliant and equipped with bank-level security, Amperos empowers teams to resolve more denials, recover more revenue, and significantly improve RCM team productivity and recovery rates.

安培罗斯健康（Amperos Health）是医疗保健领域首个专为医疗机构设计的原生人工智能拒付管理与收入追回解决方案，旨在帮助应对拒付问题并优化理赔收款流程，从而提升收入周期管理（RCM）团队的效率。完全符合HIPAA法规并配备银行级别的安全性，安培罗斯助力团队解决更多拒付问题、追回更多收入，并显著提高RCM团队的生产力和追回率。

To learn more, visit .

要了解更多信息，请访问 。

www.amperos.com

www.amperos.com

.

。

Media Contact

媒体联系人

Jared Rosen

杰瑞德·罗森

213-218-0287

213-218-0287

[email protected]

电子邮件地址

SOURCE Amperos Health

来源：Amperos Health

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示